Diamyd increases shareholding in Protein Sciences Corporation

Diamyd Medical AB announced today that the Company’s convertible promissory note in the US vaccine company Protein Sciences Corporation has been converted into shares.In fiscal year 2007/2008, Diamyd Medical invested in a convertible promissory note in the vaccine company Protein Sciences Corporation, USA. The promissory note was accounted for as an investment of SEK 6.4 million as of November 30, 2007, and has passed with an interest of 5%. After conversion of the shares, Diamyd Medical now holds about 8% of the Protein Sciences Corporation shares. Protein Sciences Corporation, founded